Addressing the immunopathogenesis of atopic dermatitis: advances in topical and systemic treatment.

Abstract

Several immunologic mediators-phosphodiesterase (PDE), interleukin (IL), small molecules, and Janus kinase-have been implicated in the pathogenesis of atopic dermatitis, and evidence has shown that blocking these mediators can help modify the disease process. Several new topical medications have been developed that target the enzyme PDE; crisaborole was… (More)
DOI: 10.12788/j.sder.2017.012

Topics

Cite this paper

@article{Eichenfield2017AddressingTI, title={Addressing the immunopathogenesis of atopic dermatitis: advances in topical and systemic treatment.}, author={Lawrence F. Eichenfield and Linda F Stein Gold}, journal={Seminars in cutaneous medicine and surgery}, year={2017}, volume={36 2 Suppl 2}, pages={S45-S48} }